supposed to Obagi C Rx System Skin Intervention pulling down

taken aback Obagi C Rx System Skin Intervention on occasion
 
Photo :Obagi C Rx System Skin Intervention

is a component Obagi C Rx System Skin Intervention Generic Name: hydroquinone, octinoxate and zinc oxide Dosage Form: topical kit Overview Side Effects Dosage Professional Pregnancy More User Reviews Support Group Q & A Pricing & Coupons Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. OBAGI-C RX SYSTEM NORMAL-OILY SKIN INTERVENTION KIT C-Cleansing Gel 6 fl. oz. (177 mL.) AM+PM A gel-based facial cleanser that clarifies and prepares your skin for absorption of the system's product ingredients. This concentrated cleanser gently removes excess oil, makeup, and other everyday impurities, and rinses clean, leaving your skin feeling fresh and clear. Slideshow Type 1 Diabetes: Symptoms, Treatments, and Breakthroughs Directions Use twice daily, morning and evening. Massage a small amount of cleanser and lukewarm water onto skin, rubbing gently in a circular motion. Rinse completely with lukewarm water and gently pat dry. Warnings Avoid getting into eyes. For external use only. Keep out of reach of children. Ingredients water (aqua), sodium laureth sulfate, sodium lauroyl oat amino acids, cocamidopropyl betaine, aloe barbadensis leaf juice (aloe barbadensis), ascorbic acid, glycerin, medicago sativa (alfalfa) extract, borago officinalis extract, chamomilla recutita (matricaria) flower extract (chamomilla recutita extract), sodium chloride, saponins, xanthan gum, phenoxyethanol, methylparaben, ethylparaben, butylparaben, propylparaben, isobutylparaben, fragrance (parfum), red 33 (CI 17200), yellow 5 (CI 19140) C-Balancing Toner 6.7 fl. oz. (198 mL.) AM+PM Specifically formulated for normal to oily skin, the C-Balancing Toner adjusts your skin's pH balance. As an essential step after cleansing, this alcohol-free, non-drying toner thoroughly removes impurities and dead skin cells to prepare the skin for the next step in your skin care regimen. s. Directions Use twice daily, in the morning and evening after cleansing. Pump a small amount (3-4 pumps) onto a cotton pad and gently wipe over entire face. Let air dry. Do not rinse. Warnings Avoid getting into eyes. For external use only. Keep out of reach of children. Ingredients water (aqua), hamamelis virginiana (witch hazel) water, propylene glycol, sodium pca, benzalkonium chloride, aloe barbadensis leaf juice (aloe barbadensis), panthenol, polyquaternium-10, phenoxyethanol, methylparaben C-Clarifying Serum Normal to Oily (Skin Lightening Serum) NDC 62032-122-10 1 fl. oz. (30 mL.) Hydroquinone USP, 4% Rx Only AM Antioxidant serum containing Vitamin C and prescription-strength hydroquinone. This patented formulation for normal to oily skin reduces the appearance of dark spots for a lighter, brighter complexion. Indications and usage The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. Dosage and administration Use once daily in the morning. Apply 5-7 drops to the entire face, or as directed by your skin care physician. Massage in gently. If no improvement is seen after three (3) months of treatment, use of this product should be discontinued. Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring. Warnings Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes thoroughly with water and contact physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Each gram of Obagi-C Rx C-Clarifying Serum Normal to Oily contains: Active Ingredient Hydroquinone USP, 4% (40 mg/g) Inactive Ingredients water, propylene glycol, alcohol denat., dipropylene glycol, ascorbic acid, propylene carbonate, sodium lauryl sulfate, fragrance See enclosed Package Insert for full prescribing information. Rx ONLY. FOR EXTERNAL USE ONLY. C-Therapy Night Cream (Skin Lightener) NDC 62032-105-36 Net wt. 2 oz. (57 g.) Hydroquinone USP, 4% Rx Only PM A rich moisturizer that works while you sleep to renew and rejuvenate your skin. The C-Therapy Night Cream is uniquely formulated with prescription-strength hydroquinone to gradually diminish the appearance of dark spots and delivers Vitamins C and E during the skin's nightly renewal process. Indications and usage The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. Dosage and Administration Use daily in the evening. Dispense a small amount (approximately 1-2 pea-sized drops) and apply to the entire face. Massage in gently. If no improvement is seen after three (3) months of treatment, use of this product should be discontinued. Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring. Warnings Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes thoroughly with water and contact physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people. Each gram of Obagi-C Rx C-Therapy Night Cream contains: Active Ingredient Hydroquinone USP, 4% (40 mg/g) Inactive Ingredients water, glycerin, cetyl alcohol, PPG-2 myristyl ether propionate, sodium lauryl sulfate, TEA-salicylate, lactic acid, phenyl trimethicone, tocopheryl acetate, sodium metabisulfite, ascorbic acid, methylparaben, disodium EDTA, propylparaben, saponins, BHT See enclosed Package Insert for full prescribing information. Rx ONLY. FOR EXTERNAL USE ONLY. Travel Bag and Patient Instruction Guide Sun Shield Broad Spectrum SPF 50 Matte Net wt. 3 oz. (85 g) This sunscreen combines UVB absorption and UVA protection in an elegant matte finish that is non-comedogenic, hypoallergenic, non-acnegenic, and dermatologist tested. Sheer, PABA free, and fragrance free for all skin types. Drug Facts Active ingredients Purpose Octinoxate 7.5% Sunscreen Zinc Oxide 10.5% Sunscreen Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun Warnings For external use only Do not use on damaged or broken skin Stop use and ask a doctor if rash occurs When using this product keep out of eyes. Rinse with water to remove. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Directions apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours children under 6 months: Ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. 2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses Inactive ingredients 1,2 hexanediol, caprylyl glycol, ceteareth-20, cetearyl alcohol, chlorphenesin, citric acid, cyclopentasiloxane, dimethicone, dimethicone crosspolymer-3, disodium EDTA, glycerin, hydrogenated palm glycerides, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, methylisothiazolinone, PEG-40 stearate, pentylene glycol, phenoxyethanol, phenyl trimethicone, polysilicone-11, polysorbate 60, potassium sorbate, sodium benzoate, sodium dihydroxycetyl phosphate, sodium polyacrylate, squalane, stearyl alcohol, tetrahexyldecyl ascorbate, tropolone, water, xanthan gum Other information store at controlled room temperature: 15 C 25 C (59 F 77 F) protect this product from excessive heat and direct sun Questions or comments? 1.800.636.7546 Monday Friday 9 a.m. 4 p.m. Pacific Time Store at controlled room temperature 15 C 25 C (59 F 77 F). Obagi-C and the Obagi logo are registered trademarks of OMP, Inc. Distributed by OMP, Inc., Long Beach, CA 90806 2012 Obagi Medical Products, Inc. All rights reserved. obagi.com Made in USA 41502111Z 5021 PRINCIPAL DISPLAY PANEL - Kit Carton NDC # 62032-523-04 OBAGI MEDICAL OBAGI-C RX SYSTEM NORMAL OILY Skin Intervention Kit Established Pharmacological Class Substance Pharmacological Class OBAGI-C RX SYSTEM C-CLEANSINGWITH VITAMIN C Cleansing (cold creams, cleansing lotions, liquids, and pads) OBAGI-C RX SYSTEM C-BALANCING TONERFOR NORMAL TO OILY SKIN Cleansing (cold creams, cleansing lotions, liquids, and pads) OBAGI-C RX SYSTEM NORMAL-OILY SKIN INTERVENTION hydroquinone, octinoxate and zinc oxide kit Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:62032-523 Packaging # Item Code Package Description 1 NDC:62032-523-04 1 KIT in 1 CARTON Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE, GLASS 30 mL Part 2 1 BOTTLE, PLASTIC 57 g Part 3 1 TUBE 85 g Part 4 1 BOTTLE, PLASTIC 177 mL Part 5 1 BOTTLE, PLASTIC 198 mL Part 1 of 5 OBAGI C RX SYSTEM C CLARIFYING SERUM hydroquinone liquid Product Information Item Code (Source) NDC:62032-122 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 mL Inactive Ingredients Ingredient Name Strength PROPYLENE GLYCOL WATER ASCORBIC ACID SODIUM LAURYL SULFATE PROPYLENE CARBONATE ALCOHOL DIPROPYLENE GLYCOL Packaging # Item Code Package Description 1 NDC:62032-122-10 1 BOTTLE, GLASS in 1 CARTON 1 30 mL in 1 BOTTLE, GLASS Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/2010 Part 2 of 5 OBAGI-C RX SYSTEM C-THERAPY SKIN LIGHTENING WITH VITAMINS C AND E hydroquinone cream Product Information Item Code (Source) NDC:62032-105 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g Inactive Ingredients Ingredient Name Strength EDETATE DISODIUM PPG-2 MYRISTYL ETHER PROPIONATE TROLAMINE SALICYLATE SODIUM LAURYL SULFATE CETYL ALCOHOL GLYCERIN LACTIC ACID .ALPHA.-TOCOPHEROL ACETATE ASCORBIC ACID SODIUM METABISULFITE WATER METHYLPARABEN PROPYLPARABEN BUTYLATED HYDROXYTOLUENE PHENYL TRIMETHICONE Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:62032-105-36 57 g in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/2004 Part 3 of 5 OBAGI-C RX SYSTEM SUN SHIELD BROAD SPECTRUM SPF 50 MATTE SUNSCREEN octinoxate and zinc oxide lotion Product Information Item Code (Source) NDC:62032-121 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (OCTINOXATE) OCTINOXATE 75 mg in 1 g ZINC OXIDE (ZINC OXIDE) ZINC OXIDE 105 mg in 1 g Inactive Ingredients Ingredient Name Strength CYCLOMETHICONE 5 WATER GLYCERIN PHENOXYETHANOL PEG-10 DIMETHICONE (600 CST) PENTYLENE GLYCOL STEARYL ALCOHOL POLYOXYL 20 CETOSTEARYL ETHER PHENYL TRIMETHICONE PEG-40 STEARATE DIMETHICONE SODIUM DIHYDROXYCETYL PHOSPHATE HYDROGENATED PALM GLYCERIDES CITRIC ACID MONOHYDRATE CETOSTEARYL ALCOHOL .ALPHA.-TOCOPHEROL ACETATE 1,2-HEXANEDIOL CAPRYLYL GLYCOL TROPOLONE CHLORPHENESIN XANTHAN GUM POTASSIUM SORBATE SODIUM BENZOATE TETRAHEXYLDECYL ASCORBATE UBIDECARENONE EDETATE DISODIUM METHYLISOTHIAZOLINONE HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) SQUALANE POLYSORBATE 60 SODIUM POLYACRYLATE (2500000 MW) Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:62032-121-90 85 g in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part352 02/12/2013 Part 4 of 5 OBAGI-C RX SYSTEM C-CLEANSING WITH VITAMIN C inert gel Product Information Route of Administration TOPICAL DEA Schedule Ingredients Ingredient Name Quantity WATER GLYCERIN PHENOXYETHANOL ETHYLPARABEN ISOBUTYLPARABEN BUTYLPARABEN PROPYLPARABEN METHYLPARABEN ASCORBIC ACID SODIUM LAUROYL OAT AMINO ACIDS COCAMIDOPROPYL BETAINE SODIUM LAURETH-3 SULFATE ALOE VERA LEAF SODIUM CHLORIDE ALFALFA CHAMOMILE XANTHAN GUM D&C RED NO. 33 FD&C YELLOW NO. 5 Product Characteristics Color ORANGE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 177 mL in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Cosmetic 01/01/2004 Part 5 of 5 OBAGI-C RX SYSTEM C-BALANCING TONER FOR NORMAL TO OILY SKIN inert liquid Product Information Route of Administration TOPICAL DEA Schedule Ingredients Ingredient Name Quantity WATER METHYLPARABEN PHENOXYETHANOL PROPYLENE GLYCOL ALOE VERA LEAF HAMAMELIS VIRGINIANA TOP WATER BENZALKONIUM CHLORIDE SODIUM PYRROLIDONE CARBOXYLATE POLYQUATERNIUM-10 (400 MPA.S At 2%) Packaging # Item Code Package Description 1 198 mL in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Cosmetic 01/01/2009 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 04/02/2013 Labeler - OMP, INC. (790553353) Establishment Name Address ID/FEI Operations PURETEK CORPORATION 785961046 MANUFACTURE(62032-523), LABEL(62032-523), PACK(62032-523) Establishment Name Address ID/FEI Operations Ei INC. 105803274 MANUFACTURE(62032-523), LABEL(62032-523), PACK(62032-523), ANALYSIS(62032-523) Establishment Name Address ID/FEI Operations MILBAR LABORATORIES 195556790 MANUFACTURE(62032-523) Establishment Name Address ID/FEI Operations Bay Cities Container Corporation 066229618 RELABEL(62032-523), REPACK(62032-523) Establishment Name Address ID/FEI Operations Swiss-American Products 611921669 MANUFACTURE(62032-523) Revised: 08/2013 OMP, INC. Next Pregnancy Warnings Print this page Add to My Med List More about hydroquinone topical Side Effects During Pregnancy Dosage Information Support Group Pricing & Coupons 5 Reviews Add your own review/rating Drug class: topical depigmenting agents Consumer resources Hydroquinone topical Hydroquinone Hydroquinone with Sunscreen Cream and Gel Professional resources Hydroquinone (AHFS Monograph) Hydroquinone Cream (FDA) Hydroquinone Cream with Sunscreens (FDA) Hydroquinone Time Release Cream (FDA) Hydroquinone (Wolters Kluwer) Other brands: Melamin , Lustra , Melquin HP , Melpaque HP , ... +19 more Related treatment guides Dermatological Disorders} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx OTC Availability Rx and/or OTC C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Manufacturers Perrigo Company Acella Pharmaceuticals, LLC Drug Class Topical depigmenting agents Related Drugs topical depigmenting agents hydroquinone topical , Melamin , Tri-Luma , Lustra Dermatological Disorders triamcinolone , clobetasol topical , betamethasone topical , Temovate , Diprolene , Analpram-HC , Celestone , urea topical , Valisone , Clobex , Proctofoam HC , sodium hyaluronate topical , hydroquinone topical , Olux , Betamethacot , Diprosone , salicylic acid topical , Melamin , Diprolene AF , Celestone Soluspan , Analpram E , Clobevate , More... Hydroquinone topical Rating 5 User Reviews 2.8 /10 5 User Reviews 2.8 Rate it!} } package


remedies Obagi C Rx System Skin Intervention is celebrated


EmoticonEmoticon